Expert NetworkExpert InterviewPRAX

Slingshot members are talking to an expert! The topic is:

Exploring the potential of Praxis' PRAX-628 & PRAX-222 in focal epilepsy & early-onset epilepsy.

Executed on:Jan 30, 2024 11:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Yale University
  • Professor of Clinical Neurology and Interim director of Epilepsy Monitoring Unit at Yale Medical School
  • Treats 500 adult patients with epilepsy and 600 patients with focal onset seizures per year
  • Research interest in new therapies for epilepsy using anticonvulsant medications and devices to treat patients with refractory epilepsy, neuromodulation, surgical treatment of seizure disorders, invasive electroencephalogram (EEG) techniques, intracranial EEG, and intraoperative EEG mapping.

Interview Goal

The aim is to delve into the therapeutic potential of PRAX-628 , developed by Praxis Precision Medicines, Inc., as a once daily, oral treatment for focal onset epilepsy. We will also be touching on PRAX-222, developed by Praxis Precision Medicines, Inc., for treating SCN2A gain-of-function mutations.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.